| Early-onset stroke and vasculopathy associated with mutations in ADA2 Q Zhou, D Yang, AK Ombrello, AV Zavialov, C Toro, AV Zavialov, ... New England Journal of Medicine 370 (10), 911-920, 2014 | 790 | 2014 |
| AMPK is essential to balance glycolysis and mitochondrial metabolism to control T-ALL cell stress and survival RJ Kishton, CE Barnes, AG Nichols, S Cohen, VA Gerriets, PJ Siska, ... Cell metabolism 23 (4), 649-662, 2016 | 225 | 2016 |
| Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma TR Gershon, AJ Crowther, A Tikunov, I Garcia, R Annis, H Yuan, CR Miller, ... Cancer & metabolism 1, 1-17, 2013 | 107 | 2013 |
| Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma IJ Dunkel, Y Khakoo, NA Kernan, T Gershon, S Gilheeney, DC Lyden, ... Pediatric blood & cancer 55 (1), 55-59, 2010 | 98 | 2010 |
| scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy JK Ocasio, B Babcock, D Malawsky, SJ Weir, L Loo, JM Simon, MJ Zylka, ... Nature communications 10 (1), 5829, 2019 | 86 | 2019 |
| Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation TR Gershon, O Oppenheimer, SS Chin, WL Gerald Neoplasia 7 (6), 575-584, 2005 | 84 | 2005 |
| Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma I Garcia, G Mayol, E Rodríguez, M Suñol, TR Gershon, J Ríos, ... Molecular cancer 9, 1-14, 2010 | 75 | 2010 |
| Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in mice SE Williams, I Garcia, AJ Crowther, S Li, A Stewart, H Liu, KJ Lough, ... Development 142 (22), 3921-3932, 2015 | 73 | 2015 |
| The leech receptor protein tyrosine phosphatase HmLAR2 is concentrated in growth cones and is involved in process outgrowth TR Gershon, MW Baker, M Nitabach, ER Macagno Development 125 (7), 1183-1190, 1998 | 72 | 1998 |
| Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma K Tech, M Deshmukh, TR Gershon Cancer letters 356 (2), 268-272, 2015 | 66 | 2015 |
| Peripheral organs control central neurogenesis in the leech CA Baptista, TR Gershon, ER Macagno Nature 346 (6287), 855-858, 1990 | 64 | 1990 |
| Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma KA Riemondy, S Venkataraman, N Willard, A Nellan, B Sanford, ... Neuro-oncology 24 (2), 273-286, 2022 | 60 | 2022 |
| Content and performance of the MiniMUGA genotyping array: a new tool to improve rigor and reproducibility in mouse research JS Sigmon, MW Blanchard, RS Baric, TA Bell, J Brennan, GA Brockmann, ... Genetics 216 (4), 905-930, 2020 | 59 | 2020 |
| Essential function of dicer in resolving DNA damage in the rapidly dividing cells of the developing and malignant cerebellum V Swahari, A Nakamura, J Baran-Gale, I Garcia, AJ Crowther, ... Cell reports 14 (2), 216-224, 2016 | 52 | 2016 |
| ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation PY Lang, GJ Nanjangud, M Sokolsky-Papkov, C Shaw, D Hwang, ... Development 143 (21), 4038-4052, 2016 | 51 | 2016 |
| Pyruvate kinase inhibits proliferation during postnatal cerebellar neurogenesis and suppresses medulloblastoma formation K Tech, AP Tikunov, H Farooq, AS Morrissy, J Meidinger, T Fish, ... Cancer research 77 (12), 3217-3230, 2017 | 50 | 2017 |
| Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation I Garcia, AJ Crowther, V Gama, C Ryan Miller, M Deshmukh, TR Gershon Oncogene 32 (18), 2304-2314, 2013 | 48 | 2013 |
| Novel use of zolpidem in cerebellar mutism syndrome C Shyu, K Burke, MM Souweidane, IJ Dunkel, SW Gilheeney, T Gershon, ... Journal of pediatric hematology/oncology 33 (2), 148-149, 2011 | 46 | 2011 |
| Poly (2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity D Hwang, T Dismuke, A Tikunov, EP Rosen, JR Kagel, JD Ramsey, C Lim, ... Nanomedicine: Nanotechnology, Biology and Medicine 32, 102345, 2021 | 43 | 2021 |
| Energy metabolism in neurodevelopment and medulloblastoma K Tech, TR Gershon Translational pediatrics 4 (1), 12, 2015 | 37 | 2015 |
